Genesis Biopharma Announces Two Hires and Two Resignations
Genesis Biopharma said Tuesday that it has named Sanford J. Hillsberg and Dr. Jay Venkatesan to its board of directors, effective in two weeks. Also, Paul Kessler and David Voyticky have resigned as directors, also effective in two weeks. Previously, Hillsberg was the chairman of the executive committee of Medco Research. Dr. Venkatesan is the founder, portfolio manager and managing director of Ayer Capital Management, a global healthcare equity fund. Based in Los Angeles, Genesis Biopharma is a company focused on developing treatments for cancer.
30 July 2013•3 mins read
